Cytori gains European OK for stem cell tech

Shares of Cytori Therapeutics (CYTX) were buoyed by the news that European regulators have approved its stem cell technology for a range of procedures including breast reconstruction surgery and tissue repair. Cytori's Celution system is designed to extract stem cells from a person's fat tissue so they can be used to create a graft that can be used in the repair work. Just last spring Cytori touted mid-stage data for its adult stem cell therapy for heart damage. "The expanded indications...

Stem cell study shows early promise for MS

A University of Bristol study has demonstrated that stem cell therapy could slow the progression of multiple sclerosis, lending hope to patients with the disease. In the trial, six MS subjects were injected with their own PCT stem cells collected from their bone marrow. Researchers then injected the stem cells into each patient's blood stream. Results from the trial indicate that the treatment could stabilize the disease. But researchers were quick to point out that the...

Cytori touts signs of efficacy in small stem cell trial

San Diego-based Cytori Therapeutics touted mid-stage results from a small trial of its experimental adult stem cell therapy for heart damage this morning. Researchers for the company zeroed in on three biomarkers for heart function, saying that they were able to divine statistically significant indicators that the stem cells improved the condition of patients who had either experienced a heart attack or were suffering from advanced coronary artery disease. Only 27 patients were recruited...

Live From BIO 2010: A chat with Stempeutics

CHICAGO - FierceBiotech sat down with BN Manohar, president of Stempeutics, which is headquartered in Bangalore and has R&D facilities in Malaysia and Manipal. The company is in the process of bringing the first stem cell therapy to the Asian market and is focusing on about eight products. It also has reached out to a number of partners and is open to inking deals with companies in the U.S. Manohar also emphasized that his is a vibrant company focused on bringing an...